LIVE
Real-Time
NEWS MONITOR
--:--:--
⬤ LOW 01 Nov 2026, 06:31 UTC

Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock

ECONOMY MARKETS
\
↗ Read Full Story ← Back to Monitors
Share: Twitter/X LinkedIn
Latest in Markets
⬤ LOW
Why the 27% Crash in ServiceNow's Stock Looks Like a Golden Opportunity
Motley Fool · 10 min ago
⬤ LOW
Investor friendly taxation amid higher yield key to retaining FPI capital, says PHDCCI’s Gupta
Hindu BusinessLine - News · 15 min ago
⬤ LOW
India's gross GST collections rise 23% in October to ₹2.31 lakh cr; net revenue jumps 26%
CNBC TV18 - Latest · 21 min ago
⬤ MEDIUM
Iran offers 48-hour Hormuz reopening plan as Trump signals progress in talks
Investing.com · 21 min ago
⬤ LOW
Energy bills help 'doesn't go far enough'
BBC News - Business · 25 min ago
Terms of Service